. Author manuscript; available in PMC: 2012 Jun 15.

Published in final edited form as: Vet Immunol Immunopathol. 2011 Mar 23;141(3-4):267–275. doi: 10.1016/j.vetimm.2011.03.016

Table 1.

Total γδ T cell responses among treatment groups at PID 5 and PID 28

	Mean frequencies of total γδ T cells among MNCs

Treatment group	PID 5				PID 28
	n	Ileum	Spleen	Blood	n	Ileum	Spleen	Blood

LAB−VirHRV−	7	4.9^C ^* (0.7)^**	9.5^A (1.2)	16.6^A (3.0)	6	17.2^A ^† (6.0)	16.7^A ^† (2.5)	9.7^A (1.5)
LAB+VirHRV−	4	19.3^A ^B (5.2)	7.9^A (0.9)	11.8^A ^B (1.6)	6	6.9^B ^† (0.9)	16.5^A ^† (2.5)	8.3^A ^B (1.5)
LAB−VirHRV+	8	11.2^B (1.8)	8.5^A (0.8)	13.2^A (1.9)	6	4.7^C ^† (0.3)	13.9^A ^† (1.0)	5.3^B ^† (0.5)
LAB+VirHRV+	4	24.9 ^A (1.8)	9.1^A (0.6)	6.6^B (1.0)	6	6.1^B ^† (0.5)	15.1^A ^† (1.9)	7.3^A ^B (1.5)

Means in the same column with different superscript letters (A, B, and C) differ significantly (Kruskal-Wallis rank sum test; p<0.05).

^**

Standard error of the mean.

^†

Indicates significant difference when compared to PID 5 for the same tissue in the same group (ANCOVA; p<0.05).